Difference between revisions of "Enzalutamide"
Jump to navigation
Jump to search
(Created page with "'''Enzalutamide''' is an antrogen receptor antagonist used to treat prostate cancer.<ref name=pmid23887973>{{Cite journal | last1 = Mitsiades | first1 = N. | title = A ro...") |
|||
| Line 8: | Line 8: | ||
[[Category:Clinical]] | [[Category:Clinical]] | ||
[[Category:Drugs]] | |||
Revision as of 14:51, 30 May 2016
Enzalutamide is an antrogen receptor antagonist used to treat prostate cancer.[1]
See also
References
- ↑ Mitsiades, N. (Aug 2013). "A road map to comprehensive androgen receptor axis targeting for castration-resistant prostate cancer.". Cancer Res 73 (15): 4599-605. doi:10.1158/0008-5472.CAN-12-4414. PMID 23887973.